Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million

Company to Accelerate Mass Manufacturing and Commercialization of Proprietary PCR-Free Multi-Omics Technology Following Year of Rapid Growth Cardea Bio, Inc., a Tech+Bio company integrating molecular biology with semiconductors via Graphene-based biology-gated Transistors, announced today a $6.5M series A extension that brings the A round total above $20M. The new capital infusion is led by the [...]

Vance Street Capital Partners with Excel Scientific, a Leading Provider of Consumable Films and Foils Used in Life Science Applications

Transaction Represents Vance Street’s Second Investment out of its Third Fund Vance Street Capital LLC (“Vance Street”), a Los Angeles-based private equity firm, today announced the acquisition of Excel Scientific, Inc. (“Excel”), a leading manufacturer of microplate sealing films and foils used by life science research, university, and testing laboratories as well as biotech companies, [...]

New England Biolabs Expands its Luna® Portfolio with the SARS-CoV-2 RT-qPCR Multiplex Assay Kit

This new research use only kit enables high throughput multiplex detection of SARS-CoV-2 nucleic acid, supports increased sample input and reduces background amplification from possible contaminating genomic DNA. IPSWICH, MA — New England Biolabs® (NEB®) today announced the launch of its Luna® SARS-CoV-2 RT-qPCR Multiplex Assay Kit for real-time detection of SARS-CoV-2 nucleic acid. This research use only (RUO) [...]

Purolite Announces Retention of Evercore Group L.L.C. to Explore Strategic Acquisitions in its Healthcare and Life Sciences Segment

Purolite Corporation today announced that it has engaged Evercore Group L.L.C. to assist the Company in growing its Healthcare and Life Sciences Segment. Purolite is exploring strategic acquisitions to accelerate the growth of its business. This announcement follows Purolite’s recent announcement that it is expanding its manufacturing capabilities to address and fulfill the increasing global [...]

Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China

Cambridge, United Kingdom: Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announced it has launched a local cloud solution that will enable researchers in China to perform more efficient genomic analysis at scale, helping to improve health outcomes. The announcement follows Congenica’s US$50m Series C [...]

Strategic Partnership Between Genedata and IDBS Aims to Further Streamline Biopharma Discovery, Development and Manufacturing

The collaboration will enable direct integration of IDBS digital solutions with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland & Boston, MA, USA—January 12, 2021—Genedata and IDBS, both leading innovators for biopharma digital transformation, have entered into a strategic partnership to create synergies between their platforms. The combined solution [...]

Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

EMERYVILLE, Calif.-- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry’s premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week. This workflow enables our customers to: Sample 4x more [...]

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

Wädenswil/Zurich, Switzerland and Saffron Walden, UK -- Sciad Newswire / Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from Creoptix AG. This instrument utilizes Grating-Coupled Interferometry (GCI) to measure target binding on sensor chips, generating binding affinity and on/off rate kinetics in a high throughput manner. This [...]

Neogen launches Reveal® Q+ for Aflatoxin M1

LANSING, Mich. -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched a quicker, easier test to detect aflatoxin M1, a known cancer-causing toxin of concern to the global dairy industry. Neogen's new Reveal® Q+ for Aflatoxin M1 can detect as little as 150 parts per trillion (ppt) of the toxin in milk samples in just [...]

Dr. Robert Plank becomes new President of HORIBA Europe GmbH

In addition to the Automotive segment, the new president of HORIBA Europe GmbH Dr. Robert Plank is now also responsible for the Process & Environmental, Scientific and Semiconductor segments HORIBA today appointed Dr. Robert Plank as the new President of HORIBA Europe GmbH with effect from January 1st, 2021. Previously leading the group's European automotive [...]

Access IBO on Knowledge Center
Register to Subscribe Login for Access

Register to Subscribe Login for Access

Lost your password? Register